Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Therapy”

3,392 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,392 results

Not applicableLooking for participantsNCT03390894
What this trial is testing

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Who this might be right for
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group 8,000
Large-scale testing (Phase 3)Ended earlyNCT00248196
What this trial is testing

COOL MI II: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Radiant Medical 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT07192588
What this trial is testing

GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Who this might be right for
Radiodermatitis; Acute
Graegis Pharmaceuticals Ltd 273
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Not applicableWithdrawnNCT02605551
What this trial is testing

Hypertension and Osteopathic Treatment

Who this might be right for
PrehypertensionHypertensionOsteopathic Manipulation+1 more
Larkin Community Hospital
Large-scale testing (Phase 3)Ended earlyNCT02664077
What this trial is testing

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer

Who this might be right for
Stage III (IIIB or IIIC) Colon Cancer
NSABP Foundation Inc 34
Large-scale testing (Phase 3)Study completedNCT03936777
What this trial is testing

Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

Who this might be right for
Dravet SyndromeLennox Gastaut SyndromeEpileptic Encephalopathy
Zogenix, Inc. 412
Not applicableStudy completedNCT00936377
What this trial is testing

Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal

Who this might be right for
Acute Alcohol Withdrawal
University of Colorado, Denver 24
Post-approval studies (Phase 4)UnknownNCT05529095
What this trial is testing

Sublingual Apomorphine in Refractory Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
William Ondo, MD 16
Large-scale testing (Phase 3)Ended earlyNCT00003645
What this trial is testing

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 64
Very early researchNot Yet RecruitingNCT06719804
What this trial is testing

Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE)

Who this might be right for
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing 15
Very early researchStudy completedNCT05704933
What this trial is testing

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Who this might be right for
Metastatic MelanomaMetastasis to Brain
H. Lee Moffitt Cancer Center and Research Institute 1
Large-scale testing (Phase 3)UnknownNCT01622361
What this trial is testing

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 290
Testing effectiveness (Phase 2)Looking for participantsNCT07331883
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 35
Large-scale testing (Phase 3)Study completedNCT00988429
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 653
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Testing effectiveness (Phase 2)Looking for participantsNCT05536505
What this trial is testing

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

Who this might be right for
MRD
Guangdong Association of Clinical Trials 180
Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Testing effectiveness (Phase 2)WithdrawnNCT04282590
What this trial is testing

Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Toray Industries, Inc
Next Page